IMARC Group's report titled “Anesthesia CO2 Absorbent Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global anesthesia CO2 absorbent market size reached US$ 73.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 111.5 Million by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028.
Anesthesia CO2 absorbent represents a specific segment within the anesthesia disposables, which is mainly used to absorb exhaled gases during anesthesia administration. It comprises strong potassium hydroxide and sodium hydroxide bases that aid in acquiring labile protons from anesthetic molecules to carbon monoxide (CO) and are instrumental in reducing anesthetic wastes. CO2 absorber devices consisting of anesthesia absorbents are incorporated into the ventilatory apparatus of the anesthesia machine between the inspiratory and expiratory limbs of a circle circuit. Certain absorbents do not contain potassium and sodium hydroxide and do not produce carbon monoxide by reacting with inhaled agents. They generally function by limiting the flow of fresh gas to closed-circuit conditions and enabling exhaled anesthetic agents to be rebreathed.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anesthesia-co2-absorbent-market/requestsample
Anesthesia CO2 Absorbent Market Trends and Drivers:
The increasing incidences of cardiac disorders, respiratory diseases, and diabetes are among the key factors stimulating the anesthesia CO2 absorbent market. Moreover, the expanding geriatric population, who are susceptible to developing medical circumstances that eventually require surgical intervention, is positively influencing the global market. Besides this, the escalating demand for anesthesia disposables, on account of the rising number of surgeries conducted across numerous healthcare settings, is acting as another significant growth-inducing factor. Furthermore, the implementation of several stringent and safety parameters by government bodies regarding the usage of anesthetic drugs and equipment in the medical sector is also propelling the market growth. Apart from this, the increasing investments in R&D activities by key market players for developing advanced formulations and the growing healthcare expenditure capacities of individuals are anticipated to fuel the anesthesia CO2 absorbent market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
· Soda Lime
· Medisorb
· Dragersorb
· Amsorb
· Litholyme
· Others
Breakup by Type:
· Premium
· Traditional
Breakup by End User:
· Hospitals
· Clinics
· Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
· Armstrong Medical Ltd. (Eakin Healthcare Group Ltd)
· Atrasorb
· Drägerwerk AG & Co. KGaA
· General Electric Company
· Intersurgical Ltd.
· Löwenstein Medical SE & Co. KG
· Micropore Inc.
· Molecular Products Group plc (Filtration Group Corporation) and Smiths Medical Inc. (ICU Medical Inc.)
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
Comments